Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 8, 1997, Pages 1794-1796

  Radwanski, Elaine ^a   Batra, Vijay ^a   Cayen, Mitchell ^a   Korduba, Chryzanta ^a   Cutler, David ^a   Affrime, Melton ^a   Nomeir, Amin ^a   Lin, C C ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ISEPAMICIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL;

EID: 0030854822     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.8.1794     Document Type: Article

References (16)

1. Daikos, G. L., G. G. Jackson, and V. T. Lolans. 1990. Adaptive resistance to aminoglycoside antibiotics from first exposure down-regulation. J. Infect. Dis. 162:414-420.
2. Ebert, S., and W. A. Craig. 1989. Impact of dosing interval on the in vivo activity of isepamicin, abstr. 941, p. 259. In Program and abstracts of the Twenty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
3. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed., p. 409-417. Marcel Dekker, Inc., New York, N.Y.
4. Glupczynski, Y., J. Dewit, R. S. Herman, R. S. Hare, G. H. Miller, and E. Yourassowsky. 1988. Comparative in-vitro activity of isepamicin (1-N-HAPA gentamicin B) and four other aminoglycosides against Gram-negative bacteria, abstr. 1494, p. 376. In Program and abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Gomez-Lus, M. L., R. Gomez-Lus, M. P. Goñi, J. Gil, and M. C. Rubio. 1988. Susceptibility of isepamicin to aminoglycoside-modifying enzymes coded by 398 clinical isolates, abstr. 1496, p. 376. In Program and abstracts of the Twenty-Eighth Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. Ikeda, D. P., S. G. Andersen, and A. L. Barry. 1982. Multiple resistance to aminoglycosides among Streptococcus faecalis isolates, abstr. 361, p. 130. In Program and abstracts of the Twenty-Second Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Jacoby, G. A., M. J. Blaser, P. Santanam, H. Hächler, F. H. Kayser, R. S. Hare, and G. H. Miller. 1990. Appearance of amikacin and tobramycin resistance due to 4′-aminoglycoside nucleotidyltransferase [ANT(4′)-II] in gram-negative pathogens. Antimicrob. Agents Chemother. 34:2381-2386.
8. Khardori, N., J. Adame, K. Jones, B. Rosenbaum, and G. Bodey. 1988. Aminoglycoside resistance patterns in clinical isolates of enterococci, abstr. A-79, p. 14. In Abstracts of the 88th Annual Meeting of the American Society for Microbiology 1988. American Society for Microbiology, Washington, D.C.
9. McCue, J. D. 1986. Cost conscious use of cephalosporins: a guide to empiric therapy, 2nd ed. Raven Press, New York, N.Y.
10. Milkovich, G., and C. J. Piazza. 1991. Considerations in comparing intravenous and intramuscular antibiotics. Chemotherapy 37(Suppl. 2):1-13.
11. Neu, H. C., and K. P. Fu. 1978. 1-N-HAPA gentamicin B. A new aminoglycoside active against gentamicin resistant isolates - activity compared to other aminoglycosides. J. Antibiot. 31:385-393.
12. Rapp, R. P. 1987. Considering product features and costs in selecting a system for intermittent intravenous drug delivery. Am. J. Hosp. Pharm. 44:2533-2538.
13. Schering-Plough Research Institute. 1993. Isepamicin registration dossier, clinical documentation. Part IV A-1. Pharmacodynamics. Schering-Plough Research Institute, Kenilworth, NJ.
14. Segal, J. L., S. R. Brunnemann, D. G. Gray, S. K. Gorden, and I. Eltorai. 1986. Impaired absorption of intramuscularly administered gentamicin in spinal cord injury. Curr. Ther. Res. 39:961-969.
15. Wang, F., J. Zhang, P. Wu, Y. Liu, and T. Tai. 1991. Antibacterial activity of isepamicin compared with six aminoglycosides, abstr. 723. In Program and abstracts of the 17th International Congress of Chemotherapy, Berlin. Futuramed Verlagsgesellschaft, Munich, Germany.
16. Woloj, M., M. Catalano, K. J. Shaw, F. Sabatelli, R. S. Hare, and G. H. Miller. 1989. Mechanisms of aminoglycoside resistance in a large multi-hospital study in Argentina, abstr. 676, p. 214. In Program and abstracts of the Twenty-Ninth Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.